Cyxone AB Financials
| CYXO Stock | SEK 0.03 0 5.08% |
Cyxone |
Understanding current and past Cyxone AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cyxone AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Cyxone AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Cyxone AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cyxone AB. Check Cyxone AB's Beneish M Score to see the likelihood of Cyxone AB's management manipulating its earnings.
Cyxone AB Stock Summary
Cyxone AB competes with Bavarian Nordic, BioPorto, Zaptec AS, and CBrain AS. Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007815428 |
| Business Address | Adelgatan 21, Malm, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.cyxone.com |
| Phone | 46 7 08 88 21 72 |
| Currency | SEK - Swedish Kronor |
You should never invest in Cyxone AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cyxone Stock, because this is throwing your money away. Analyzing the key information contained in Cyxone AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cyxone AB Key Financial Ratios
Cyxone AB's financial ratios allow both analysts and investors to convert raw data from Cyxone AB's financial statements into concise, actionable information that can be used to evaluate the performance of Cyxone AB over time and compare it to other companies across industries.| Return On Equity | -1.07 | |||
| Return On Asset | -0.59 | |||
| Target Price | 4.2 | |||
| Beta | 0.54 |
Cyxone Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cyxone AB's current stock value. Our valuation model uses many indicators to compare Cyxone AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cyxone AB competition to find correlations between indicators driving Cyxone AB's intrinsic value. More Info.Cyxone AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyxone AB's earnings, one of the primary drivers of an investment's value.Cyxone AB Systematic Risk
Cyxone AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cyxone AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Cyxone AB correlated with the market. If Beta is less than 0 Cyxone AB generally moves in the opposite direction as compared to the market. If Cyxone AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cyxone AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cyxone AB is generally in the same direction as the market. If Beta > 1 Cyxone AB moves generally in the same direction as, but more than the movement of the benchmark.
Cyxone AB November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cyxone AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cyxone AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cyxone AB based on widely used predictive technical indicators. In general, we focus on analyzing Cyxone Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cyxone AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 10.53 | |||
| Information Ratio | 0.0016 | |||
| Maximum Drawdown | 90.37 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 9.09 |
Additional Tools for Cyxone Stock Analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.